Frontiers in Oncology (Apr 2023)

Prognostic role of plasma vitamin D and its association with disease characteristics in germ cell tumours

  • Peter Lesko,
  • Barbora Vlkova,
  • Katarina Kalavska,
  • Valentina De Angelis,
  • Vera Novotna,
  • Jana Obertova,
  • Zuzana Orszaghova,
  • Patrik Palacka,
  • Katarina Rejlekova,
  • Zuzana Sycova-Mila,
  • Boris Kollarik,
  • Ramadan Aziri,
  • Daniel Pindak,
  • Jozef Mardiak,
  • Michal Chovanec,
  • Peter Celec,
  • Michal Mego

DOI
https://doi.org/10.3389/fonc.2023.1149432
Journal volume & issue
Vol. 13

Abstract

Read online

BackgroundTesticular cancer is the most common malignancy among young men. Vitamin D has pluripotent effects on cancer pathogenesis and plays a role in the metastatic cascade. The aim of this study is to analyze plasma vitamin D in association with clinico-pathological findings and prognosis in patients with germ-cell tumors (GCTs).MethodsThis study included 120 newly diagnosed and/or relapsed GCT patients treated from April 2013 to July 2020, for whom plasma was available in the biobank. Blood samples were drawn the 1st chemotherapy cycle as well as before the 2nd cycle. Plasma vitamin D was measured using ELISA and correlated with disease characteristics and the outcome. For survival analysis, the cohort was dichotomized into “low” and “high” based on median vitamin D.ResultsThere was no significant difference in vitamin D plasma levels between healthy donors and GCT patients (p = 0.71). Vitamin D level was not associated with disease characteristics except for brain metastases, where patients with brain metastases had a vitamin D level that was 32% lower compared to patients without brain metastases, p = 0.03. Vitamin D was also associated with response to chemotherapy, with an approximately 32% lower value in patients with an unfavorable response compared to a favorable response, p = 0.02. Moreover, low plasma levels of vitamin D were significantly associated with disease recurrence and inferior progression-free survival (PFS), but not with overall survival (OS) (HR = 3.02, 95% CI 1.36–6.71, p = 0.01 for PFS and HR = 2.06, 95% CI 0.84–5.06, p = 0.14 for OS, respectively).ConclusionOur study suggests the prognostic value of pretreatment vitamin D concentrations in GCT patients. Low plasma vitamin D was associated with an unfavorable response to therapy and disease recurrence. However, it remains to be determined whether the biology of the disease confirms a causative role for low vitamin D and whether its supplementation affects the outcome.

Keywords